BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3089256)

  • 1. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with amiodarone in the treatment of supraventricular and ventricular tachyarrhythmia].
    Vejby-Christensen H; Bjerregaard P; Andreasen F; Gøtzsche H
    Ugeskr Laeger; 1984 Jul; 146(31):2308-11. PubMed ID: 6393491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of treatment with oral amiodarone in patients with malignant ventricular arrhythmias].
    Grande A; Farré J
    Rev Esp Cardiol; 1987; 40(5):317-26. PubMed ID: 3454969
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
    McGovern B; Ruskin JN
    Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig].
    Hottinger S; Mettler D; Leupi F; Gertsch M
    Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience in the treatment of tachyarrhythmias with amiodarone].
    Sun JP
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Mar; 11(1):2-5. PubMed ID: 6884199
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient)].
    Husson J
    Lille Med; 1975 Feb; 20(2):109-12. PubMed ID: 1142986
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
    Waxman HL
    Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
    [No Abstract]   [Full Text] [Related]  

  • 13. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
    Van Schepdael J; Solvay H
    Schweiz Rundsch Med Prax; 1975 Jan; 64(2):30-4. PubMed ID: 56002
    [No Abstract]   [Full Text] [Related]  

  • 15. Amiodarone. Therapeutics and guidelines.
    Frei J
    Prog Cardiovasc Nurs; 1989; 4(4):113-8. PubMed ID: 2602355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amiodarone in ventricular tachycardias].
    Steinbeck G; Manz M; Lüderitz B
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):723-7. PubMed ID: 6813695
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amiodarone in the treatment of severe supraventricular tachycardias].
    Lukl J; Cernosek B; Rezácová M; Heinc P
    Vnitr Lek; 1986 Apr; 32(4):386-92. PubMed ID: 3727426
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.